Welcome to PATH

Path Members The Programs for Assessment of Technology in Health (PATH) Research Institute consists of multiple research programs in economic evaluation and health technology assessment (HTA). PATH's educational and research activities are separated into 5 primary programs: the Field Evaluation and Economic Assessment Program (FEEAP); the Health Technology Assessment Program (HTAP); the Trial and Economic Modelling Methodology Program (TEMMP); the St. Joseph's Healthcare Hamilton (SJHH) Health Technology Assessment Appraisal & Review Program (SHARP); and the Health Technology Assessment Educational Learning Program (HELP). The PATH Research Institute is affiliated with the Centre for Evaluation of Medicines (CEM) at SJHH and the Department of Clinical Epidemiology and Biostatistics at McMaster University.

Recent News

Congratulations to Dr. Ed Hughes, recipient of the Dr. Biljan Memorial Award. Collaborative work with PATH members will be presented at the CFAS 2011 Annual Meeting. See details in "Recent Presentations".
PATH Annual Report 2010
Congratulations to Na Guo, the 2011 Bernie O’Brien Fellow. The fellowship is awarded to exceptional post-doctoral fellows in health economics, health technology assessment, health policy analysis or related fields of research at McMaster University.

Recent Reports

Chandra K, Blackhouse G, McCurdy B, Bornstein M, Campbell K, Costa V, Franek J, Kaulback K, Levin L, Sehatzadeh S, Thabane M, Sikich N, Goeree R. Cost-effectiveness of interventions for chronic obstructive pulmonary disease using an Ontario policy model. (forthcoming).
Bowen JM, Snead OC, Hopkins RB, Elliott I, Burke N, Atkin J, Hebbard M, Brown L, Xie F, Tarride J-E, O’Reilly DJ, Goeree R. Diagnostic evaluation of infants, children and adolescents with epilepsy for surgery candidacy and the role of magnetoencephalography (MEG) [Report No. FEEAP-HTA013a-2011.REP]. Hamilton (ON): Programs for Assessment of Technology in Health, St. Joseph’s Healthcare Hamilton/McMaster University; 2011 pdf
O'Reilly DJ, Blackhouse G, Paquette-Warren J, Fournie M, Goeree R, Harris SB. Long-term cost-utility of a quality improvement collaborative focusing on patients with type 2 diabetes mellitus. Report No.: TEMMP-D034-2011-REP. Prepared for the Partnerships in Health Project. February 8, 2011 (21p.).

More Reports

Recent Presentations

Tarride J-E. Health Status, Hospitalizations, Day Procedures and Physician Costs Associated with Body Mass Index (BMI) Levels in Ontario, Canada. Invited presentation at the CHEPA Seminar Series, McMaster University, Hamilton, ON, December 14, 2011.
Bowen J, O’Reilly D, Tarride JE, Xie F, Blackhouse G, Hopkins R, Campbell K, Nunes E, Goeree R. Standardization Considerations for Planning, Conducting Analyzing and Reporting EXCITE Field Evaluations. Invited presentation to the Ottawa Hospital Research Instiute, Ottawa, ON, December 9, 2011.
O’Reilly DJ, Tarride JE, Bowen JM, Xie F, Goeree R. Health Technology Assessment in Ontario. Invited presentation at the Canadian Medical Device Market Access & Government Affairs Conference, Toronto, ON December 5-6, 2011.

Recent Publications

Blackhouse G, Assasi N, Xie F, Marshall J, Irvine EJ, Gaebel K, Campbell K, Hopkins R, O'Reilly D, Tarride J-E, Goeree R. Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-alpha drugs for refractory Crohn's disease. Journal of Crohns and Colitis 2012;6(1):77-85.
Tarride JE, Harrington K, Balfour R, Simpson P, Foord L, Anderson L, Lakey W. Partnership in employee health. A workplace health program for British Columbia Public Service Agency (Canada). Work 2011;40(4):459-71
Pullenayegum EM, Tarride JE, Xie F, O'Reilly D. Calculating utility decrements associated with an adverse event: marginal Tobit and CLAD coefficients should be used with caution. Medical Decision Making 2011;31(6):790-9.
Xie F, Oremus M, Gaebel K. Measuring health-related quality-of-life for Alzheimer's disease using the general public. Quality of Life Research 2011 [epub].

More Publications